Correlation Between Caribou Biosciences and Corvus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Caribou Biosciences and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Corvus Pharmaceuticals.
Diversification Opportunities for Caribou Biosciences and Corvus Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Caribou and Corvus is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Corvus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Corvus Pharmaceuticals
Given the investment horizon of 90 days Caribou Biosciences is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Caribou Biosciences is 1.1 times less risky than Corvus Pharmaceuticals. The stock trades about -0.05 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 158.00 in Corvus Pharmaceuticals on September 24, 2024 and sell it today you would earn a total of 341.00 from holding Corvus Pharmaceuticals or generate 215.82% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Corvus Pharmaceuticals
Performance |
Timeline |
Caribou Biosciences |
Corvus Pharmaceuticals |
Caribou Biosciences and Corvus Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Corvus Pharmaceuticals
The main advantage of trading using opposite Caribou Biosciences and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Corvus Pharmaceuticals vs. Fate Therapeutics | Corvus Pharmaceuticals vs. Sana Biotechnology | Corvus Pharmaceuticals vs. Caribou Biosciences | Corvus Pharmaceuticals vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |